4893 items matching your search terms.

Analysis of the barriers and enablers to implementing lifestyle management practices for women with PCOS in Singapore

Ko, H. Teede, H. Moran, L.
BMC RESEARCH NOTES, 2016     DOI:10.1186/s13104-016-2107-2

Chemical agents for the sedation of agitated patients in the ED: a systematic review

Korczak, V. Kirby, A. Gunja, N.
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016     DOI:10.1016/j.ajem.2016.09.025

Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis

Kothur, K. Wienholt, L. Mohammad, S. S. Tantsis, E. M. Pillai, S. Britton, P. N. Jones, C. A. Angiti, R. R. Barnes, E. H. Schlub, T. Bandodkar, S. Brilot, F. Dale, R. C.
PLOS ONE, 2016     DOI:10.1371/journal.pone.0161656

The Relationship between Dyslipidemia and Acute Axonal Function in Type 2 Diabetes Mellitus In Vivo

Kwai, N. C. Nigole, W. Poynten, A. M. Brown, C. Krishnan, A. V.
PLOS ONE, 2016     DOI:10.1371/journal.pone.0153389

Rate of disease progression: a prognostic biomarker in ALS

Labra, J. Menon, P. Byth, K. Morrison, S. Vucic, S.
JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY, 2016     DOI:10.1136/jnnp-2015-310998

The Cost-Effectiveness of the Integration of Nalmefene within the UK Healthcare System Treatment Pathway for Alcohol Dependence

Laramee, P. Bell, M. Irving, A. Brodtkorb, T. H.
ALCOHOL AND ALCOHOLISM, 2016     DOI:10.1093/alcalc/agv140

Suboptimal behavior re: overnight glycemia in type 1 diabetes adults

Larsson, C Januszewski, AS McGrath, R Fulcher, G O'Neal, D Ward, G MacIsaac, RJ Ludvigsson, J Jenkins, AJ

Efficacy of a novel antibody-drug conjugate, ABT-414, with temozolomide in recurrent glioblastoma

Lassman, A.B. Van Den Bent, M. Gan, H.K. Reardon, D.A. Kumthekar, P. Butowski, N. Lwin, Z. Mikkelsen, T. Nabors, L.B. Papadopoulos, K.P. Penas-Prado, M. Simes, J. Wheeler, H. Gomez, E. Lee, H.J. Roberts-Rapp, L. Xiong, H. Bain, E. Holen, K. Merrell, R.

Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumors: updated analysis of an Australian multicenter phase II trial (3033)

Lawrence, N. Grimison, P. Stockler, M. Martin, A. Buizen, L. Thomson, D. Gebski, V. Friedlander, M. Yeung, A. Gurney, H. Rosenthal, M. Singhal, N. Kichenadasse, G. Wong, S. Lewis, C. Vasey, P. Toner, G.

Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ-cell tumors: updated analysis of an Australian multicenter phase II trial

Lawrence, N. Martin, A. Toner, G. Stockler, M. Buizen, L. Thomson, D. Gebski, V. Friedlander, M. Yeung, A. Gurney, H. Rosenthal, M. Singhal, N. Kichenadasse, G. Wong, S. Lewis, C. Vasey, P. Grimison, P. ANZUP,

Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Lawrence, N. Martin, A. Toner, G. Stockler, M. Buizen, L. Thomson, D. Gebski, V. Friedlander, M. Yeung, A. Wong, N. Gurney, H. Rosenthal, M. Singhal, N. Kichenadasse, G. Wong, S. Lewis, C. Vasey, P. Grimison, P.
ANNALS OF ONCOLOGY, 2016     DOI:10.1093/annonc/mdw313

Valuing the effect sizes hypothesized in phase 3 trials published from 2005 to 2015

Lawrence, N. Roncolato, F. Stockler, M

Effect sizes hypothesized in phase 3 trials published from 2005 to 2015 versus recommendations of the ASCO working party on clinically meaningful outcomes

Lawrence, N. Roncolato, F. Stockler, M. R.

Valuing the benefits of new anticancer drugs

Lawrence, N. J. Salkeld, G. Stockler, M. R. Karikios, D.

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial

Ledermann, J. A. Embleton, A. C. Raja, F. Perren, T. J. Jayson, G. C. Rustin, G. J. S. Kaye, S. B. Hirte, H. Eisenhauer, E. Vaughan, M. Friedlander, M. Gonzalez-Martin, A. Stark, D. Clark, E. Farrelly, L. Swart, A. M. Cook, A. Kaplan, R. S. Parmar, M. K. B. Icon collaborators
LANCET, 2016     DOI:10.1016/S0140-6736(15)01167-8